AMSBIO
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.
Latest AMSBIO Content
Product News
Sensitive Detection of Cell Culture Mycoplasma Infection
The MycoScope™ Mycoplasma PCR detection kit from AMSBIO uses polymerase chain reaction (PCR) technology to detect mycoplasma infections in less than 3 hours.
Product News
Culture Techniques for Drug Discovery and Therapeutics
AMSBIO has published an informative online article that reviews the importance of culture techniques for induced pluripotent stem cells (iPSCs), which provide an invaluable resource for drug discovery and therapeutic applications.
Product News
Genetically Engineered iPSCs Offer Improved Efficiency and Cost Savings
AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research.
Product News
GLP-1R Reporter Cell Line for Diabetes / Obesity Research
AMSBIO has launched a Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line.
Product News
Products for Sustainable Food Development
AMSBIO offers a range of kits, media and reagents enabling development of food in a way that is not wasteful of our natural resources and is not detrimental to the environment or consumer health.
Product News
GMP Compliant Materials and Support for ATMP Manufacturing
AMSBIO is dedicated to helping its customers seamlessly translate their cutting-edge research into production products for clinical therapy. A comprehensive new resource has been added to the website.
Product News
GMP Collagen Type I Additive for Reinforcing Bioprinted Constructs
Produced using dry-spun 50 µm Collagen Type I fibers, AMSBIO has introduced the innovative CollaFibR™ additive proven to increase the shape fidelity and biological relevance of bioprinted constructs in hydrogels and bioinks.
Product News
GMP Compliant Cell Culture Medium Streamlines API Manufacture
AMSBIO has launched an enhanced GMP-compliant version of its animal-origin-free, chemically defined StemFit™ iPSC expansion medium.
Product News
Regulatory Compliant Tissue Microarrays
AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.
Product News
Products and Services for Diversifying Preclinical Models
AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.
Advertisement
